Outcome of Down syndrome associated acute lymphoblastic leukaemia treated on a contemporary protocol

We report the outcome for children and young people with Down syndrome-associated acute lymphoblastic leukaemia (DS-ALL) treated on a contemporary protocol. Compared with non-DS ALL, patients with DS-ALL had an inferior event-free survival (65·6% vs. 87·7% at 5 years; P < 0·00005) and overall...

Descrizione completa

Dettagli Bibliografici
Autori principali: Patrick, K, Wade, R, Goulden, N, Rowntree, C, Hough, R, Moorman, A, Mitchell, C, Vora, A
Natura: Journal article
Lingua:English
Pubblicazione: Blackwell Publishing Ltd 2014